Cite
HARVARD Citation
Fuchs, B. et al. (2023). The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro. Journal of biomaterials applications. pp. 1858-1873. [Online].